Antibacterial-coated Sutures at Time of Cesarean
Stopped early · Phase 4
Conditions studied: Surgical Site Infection, Surgical Wound Infection, Cesarean Section; Infection, Cesarean Section Complications
In brief
Abdominal closure with antibacterial-coated sutures has been shown to reduce wound infections after a number of surgical procedures, but none of the previous trials included cesarean delivery. Our objective is to determine whether use of antibacterial-coated sutures reduces surgical site infection (SSI) after cesarean delivery.
Key facts
- Study ID
- NCT03386240
- Run by
- The University of Texas Medical Branch, Galveston
- People needed
- 1169
- Starts
- 2018-01-09
- Expected to finish
- 2024-11-22
- Last updated by the study team
- 2026-06-22
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- 18-50 years of age.
- Women ≥ 24 weeks' viable gestation.
- To undergo cesarean delivery.
You may not qualify if…
- Patient unwilling or unable to provide consent.
- No prenatal care or a non-resident patient who is unlikely to be followed-up after delivery.
- Immunosuppressed patients: i.e., taking systemic immunosuppressant or steroids (e.g. transplant patients; not including steroids for lung maturity), HIV with CD4<200, or other.
- Decision to use other than suture closure (e.g. secondary wound closure, mesh closure).
- Skin infection.
- Coagulopathy.
- High likelihood of additional surgical procedure beyond cesarean (e.g. scheduled hysterectomy, bowel or adnexal surgery).
- Allergy to Triclosan.
- Incarcerated individuals.
Where it is running
- University of Texas Medical Branch in Galveston — Galveston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.